These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 775798)

  • 1. [Disturbances of lipid metabolism following renal transplantation (author's transl)].
    Zazgornik J; Bayer PM; Schmidt P; Pils P; Bratusch-Marrain P; Kopsa H
    Wien Klin Wochenschr; 1975 Oct; 87(19):648-50. PubMed ID: 775798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia following renal transplantation.
    Ibels LS; Alfrey AC; Subryan V; Weil R
    Trans Am Soc Artif Intern Organs; 1976; 22():46-53. PubMed ID: 781985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
    Frank O
    Wien Klin Wochenschr; 1974 May; 86(9):252-6. PubMed ID: 4363464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation].
    Luci V; Wichmann T; Giesselmann M; Koall W; Mampel E
    Z Gesamte Inn Med; 1983 Mar; 38(5):153-7. PubMed ID: 6344469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of cardiovascular risk factors in renal transplant patients (author's transl)].
    Zazgornik J; Balcke P; Schmidt P; Kopsa H
    Wien Klin Wochenschr; 1978 Jun; 90(13):466-8. PubMed ID: 351973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of pancreas transplantation on triglyceride metabolism].
    Pálos G; Domán J; Föger B; Karádi I; Romics L
    Orv Hetil; 1995 Nov; 136(48):2609-14. PubMed ID: 8539060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of renal transplantation with a minimal steroid regime on uraemic hypertriglyceridaemia.
    Turgan C; Russell GI; Baker F; Walls J
    Q J Med; 1984; 53(210):271-7. PubMed ID: 6379726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Altered plasma lipid and protein patterns in schizophrenic patients (author's transl)].
    Roccatagliata G; Balestreri R; Ivaldi M; Arcuri T; Caja A
    Riv Patol Nerv Ment; 1980; 101(2):94-105. PubMed ID: 7291887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)].
    Assmann G; Schriewer H
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):449-52. PubMed ID: 6769013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 18. Medroxyprogesterone acetate and lipid metabolic changes.
    Teichmann AT; Wander HE; Cremer P; Wieland H; Kuhn W; Nagel GA; Seidel D
    Arzneimittelforschung; 1987 May; 37(5):573-7. PubMed ID: 2956958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.